• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ikena Oncology, Inc. - Common Stock (NQ:IKNA)

1.380 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ikena Oncology, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company
July 23, 2025
From Ikena Oncology, Inc.
Via GlobeNewswire
On Thursday, there are stocks with unusual volume. Let's take a look.
July 17, 2025
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 15, 2025
Via Benzinga
Tuesday's after hours session: top gainers and losers
July 15, 2025
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
The Analyst Landscape: 4 Takes On Ikena Oncology
March 19, 2024
Via Benzinga
Ikena Oncology: Q4 Earnings Insights
March 12, 2024
Via Benzinga
Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals
July 15, 2025
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Merger with Inmagene Biopharmaceuticals
July 11, 2025
From Ikena Oncology, Inc.
Via GlobeNewswire
Traws Pharma Announces Management Updates
March 28, 2025
From Traws Pharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 23, 2024
Via Benzinga
Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement
December 23, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology Reports Third Quarter 2024 Financial Results
November 07, 2024
Strong financial position with $138 million in cash and investments at close of third quarter 
From Ikena Oncology, Inc.
Via GlobeNewswire
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q2 2024
August 09, 2024
IKNA stock results show that Ikena Oncology beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Ikena Oncology Reports Second Quarter 2024 Financial Results
August 08, 2024
Strong financial position with $145 million in cash and investments at close of second quarter 
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology Discontinues IK-930 Program And Cuts Workforce, Analyst Calls It 'Disappointing'
May 29, 2024
Ikena Oncology halts its IK-930 program after reviewing clinical data and resources, focusing on the novel MEK-RAF molecular glue, IK-595. 
Via Benzinga
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 29, 2024
Via Benzinga
This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
May 29, 2024
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 29, 2024
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 29, 2024
It's time to start the day with a breakdown of the biggest pre-market stock movers traders are going to want to watch on Wednesday morning! 
Via InvestorPlace
UPDATE – Ikena Oncology Announces Strategic Update
May 28, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology Announces Strategic Update
May 28, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q1 2024
May 13, 2024
IKNA stock results show that Ikena Oncology beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
May 13, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
April 10, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
March 12, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference
February 27, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
February 21, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 16, 2024
Via Benzinga
Ikena Oncology Refocuses on Key Programs: Analysts Maintain Outperform Ratings Amid Strategic Organizational Changes
January 19, 2024
Ikena Oncology optimizes resources for targeted oncology programs IK-930 & IK-595. Clinical updates expected H2 2024. Workforce reduced by 35%. Financially secure with $175M cash. Strategic focus on... 
Via Benzinga
Ikena Oncology Outlines Key Priorities and Provides Corporate Updates
January 18, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap